This antioxidant function may provide a selective pressure to maintain the upregulation of Mirk seen in about 90% of pancreatic cancers [12], and the amplification of the Mirk gene in a subset of these cancers. The gene discussed is DYRK1B; the disease is familial pancreatic carcinoma.